Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ujiplus for Schistosoma mansoni in School Children
NCT04679831Phase 3Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- May 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Kenya Medical Research Institute. Primary endpoint: Parasite egg count at 90 days. Started May 2021; status: completed.
Beyond the preview
Go deeper on NCT04679831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04679831.